1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with iberiotoxin in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (iberiotoxin) | Trials (iberiotoxin) | Recent Studies (post-2010) (iberiotoxin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 777 | 0 | 150 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isono, K; Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J; Yamawaki, I | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and iberiotoxin
| Article | Year |
|---|---|
A human bronchial epithelial cell line releases arginine vasopressin: involvement of Ca2+ -activated K+ channels.
Topics: Arginine Vasopressin; Bradykinin; Bronchi; Carbamates; Cell Line; Epithelial Cells; Humans; Large-Conductance Calcium-Activated Potassium Channels; Peptides; Phenylcarbamates; Platelet Activating Factor; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Type C Phospholipases | 1998 |